BRIEF-Glenmark Pharma Says Ichnos Glenmark Innovation (IGI), Abbvie Announce Exclusive Global Licensing Agreement

Reuters
Jul 10, 2025
BRIEF-Glenmark Pharma Says Ichnos Glenmark Innovation <a href="https://laohu8.com/S/IGI">$(IGI)$</a>, Abbvie Announce Exclusive Global Licensing Agreement

July 10 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS:

  • ICHNOS GLENMARK INNOVATION (IGI) AND ABBVIE ANNOUNCE EXCLUSIVE GLOBAL LICENSING AGREEMENT

  • LICENSING AGREEMENT FOR ISB 2001

  • IGI WILL RECEIVE AN UPFRONT PAYMENT OF $700 MILLION, ELIGIBLE TO RECEIVE UP TO $1.225 BILLION

Source text: ID:nBSE3Lp8jW

Further company coverage: GLEN.NS

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10